Assessment of real-world treatment patterns and outcomes of olutasidenib in patients with mutated isocitrate dehydrogenase 1 Acute Myeloid Leukemia previously treated with venetoclax using electronic health record dataCatherine Lai, Aaron Sheppard, Pinkal Desai et al.|Blood|2025Cited by 0
Real-world treatment patterns and outcomes with olutasidenib after venetoclax in <i>IDH1</i> -mutated AML using EHR data.Yasmin Abaza, Catherine Lai, Amber Thomassen et al.|Journal of Clinical Oncology|2026Cited by 0